KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Taxes (2016 - 2026)

Gsk has reported Current Taxes over the past 18 years, most recently at -$748.2 million for Q1 2026.

  • For Q1 2026, Current Taxes rose 5.4% year-over-year to -$748.2 million; the TTM value through Mar 2026 reached -$748.2 million, up 5.4%, while the annual FY2025 figure was -$662.4 million, 173.41% down from the prior year.
  • Current Taxes for Q1 2026 was -$748.2 million at Gsk, down from -$662.4 million in the prior quarter.
  • Over five years, Current Taxes peaked at $902.3 million in Q4 2024 and troughed at -$922.7 million in Q2 2024.
  • A 5-year average of -$371.7 million and a median of -$515.4 million in 2023 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: soared 84.62% in 2022 and later plummeted 173.41% in 2025.
  • Year by year, Current Taxes stood at $552.4 million in 2022, then rose by 12.33% to $620.6 million in 2023, then surged by 45.4% to $902.3 million in 2024, then plummeted by 173.41% to -$662.4 million in 2025, then decreased by 12.95% to -$748.2 million in 2026.
  • Business Quant data shows Current Taxes for GSK at -$748.2 million in Q1 2026, -$662.4 million in Q4 2025, and -$437.2 million in Q3 2025.